Celcuity teams up with Bayer for Phase Ib/II prostate cancer trial

Celcuity is planning a Phase Ib/II trial for its prostate cancer therapy. Credit: FatCamera via Getty Images. US-based Celcuity has announced a new clinical trial collaboration and supply agreement with Bayer to provide its cancer drug Nubeqa (darolutamide) for a planned Phase Ib/II clinical trial. Celcuity plans to initiate […]

Click here to view original web page at www.pharmaceutical-technology.com